Artificial intelligence is harnessed by this innovative company to enhance heart disease diagnoses, particularly in regions where medical specialists are scarce.
In the rapidly evolving world of medicine, a French startup named DESKi is making waves with its innovative solution for heart disease detection, called HeartFocus. This AI-powered software is promising to redefine the future of cardiac diagnostics, making quality care faster, more efficient, and more equitable.
HeartFocus aids non-invasive echocardiograms and early heart disease detection by providing AI-powered live guidance during ultrasound imaging. This guidance includes real-time cues and enhanced view detection, helping users capture diagnostic-quality heart images more efficiently and accurately.
In resource-limited environments where specialized cardiology experts and advanced equipment may not be available, HeartFocus offers a game-changing solution. It enables healthcare providers or trained personnel to perform echocardiograms more effectively by compensating for limited experience with intelligent, on-device assistance. The AI models powering the app are continuously improved with large datasets to ensure robust performance with portable ultrasound probes, such as Butterfly Network Probes, frequently used in point-of-care and low-resource settings.
Dr. Bertrand Moal, co-founder of DESKi, stated that HeartFocus technology improves precision and expands access to life-saving tools. Sophie Pierrin Lepinard, Director of Alliances at BNP Paribas Développement, highlighted that HeartFocus is uniquely positioned to transform global cardiovascular disease detection and management.
The funding raised by DESKi aims to reinforce its vision of democratizing access to AI-assisted cardiac diagnostics. The startup recently closed a $6 million seed funding round, led by impact fund Racine, with French insurer MGEN and managed by Serena, along with other investors like BNP Paribas Développement and Makesense.
The cardiac diagnosis market is projected to grow from $8.4 billion in 2025 to $26.3 billion in 2034, underscoring the immense potential of AI-driven solutions like HeartFocus. Moreover, the broader field of AI in healthcare is poised for significant growth, with Harvard scientists recently creating AI that predicts survival probabilities in cancer patients.
As these technologies become more accessible and scalable, in a few years, they will drive a future where prevention systems are accessible everywhere on the planet. Emerging startups like DESKi are indeed promising to redefine the future of medicine, making quality care faster, more efficient, and more equitable.
[1] Source: DESKi's official website and press releases.
- The AI-powered software, HeartFocus, developed by French startup DESKi, is set to revolutionize the field of medical-conditions, particularly cardiovascular-health, by providing a solution that aids in early detection and non-invasive echocardiograms, even in resource-limited environments.
- In the burgeoning realm of science and health-and-wellness, AI is proving to be a transformative force, as demonstrated by HeartFocus' capabilities in cardiac diagnostics, which could potentially increase precision and expand access to life-saving tools.
- The future of medicine is increasingly intertwined with technology, and heart disease detection is no exception. Companies like DESKi, propelled by funding and backed by investors, are leading this technological shift, promising to make quality care faster, more efficient, and more equitable on a global scale.
